白细胞分离术市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00005515
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 190
Buy Now

[研究报告]白细胞去除术市场预计将从 2021 年的 7448 万美元增至 2028 年的 1.339 亿美元;预计 2021 年至 2028 年复合年增长率为 8.7%。

白细胞去除术是一种让白细胞参与人体免疫反应的程序从血液样本中分离出来。它是一种特殊形式的单采术,其中获得血液成分,例如红细胞或血小板,而剩余的血液则恢复循环。白细胞去除术通常用于减少非常高的白细胞 (WBC) 计数,例如慢性淋巴细胞白血病 (CLL) 等慢性血癌。它还可以完成以获得白细胞用于以后的移植,例如控制癌症化疗期间白细胞计数的突然下降。另一种用途是作为新型免疫疗法的一部分,称为嵌合抗原受体 (CAR) T 细胞疗法,帮助对抗白血病、前列腺癌和其他形式的癌症。白细胞分离术可以在要求治疗的人身上完成(自体分离术),也可以在供以后移植的捐赠者身上完成(同种异体分离术)。目前,白细胞去除术通常用于治疗各种疾病,并且也用于诊断目的,因为它可以增加循环肿瘤细胞的产量。无偿献血人数不断增加、血液疾病发病率上升以及老年人口激增等因素正在推动白细胞分离术市场的增长。然而,白细胞去除术的高昂成本在一定程度上阻碍了市场的增长。

白细胞去除术市场利润丰厚的区域


市场洞察

输血是各国卫生基础设施和政策的重要组成部分。医疗行业的进步导致严重疾病和伤害的治疗程序得到改善,最终推动了患者对输血的需求。生存。人们越来越认识到医疗保健服务中输血和血液供应的重要性,导致愿意为医疗原因献血的人数增加。根据世界卫生组织 (WHO) 的数据,2018 年全球报告的献血量约为 1.174 亿次。献血者通常分为自愿无偿献血者、有偿献血者和家庭/替代献血者,根据 WHO 的说法,自愿/无偿献血者分为自愿/无偿献血者和无偿献血者。是可靠和充足血液供应的主要来源。根据世界卫生组织2019年数据,2008年至2015年,全球139个国家的自愿无偿献血者增加了1160万人次。在低收入和中等收入国家,献血的趋势也越来越突出。根据 2017 年 CAG 年会期间提供的数据,2016 年对 1,087 名患者进行了约 13,000 次手术。自愿献血者数量激增最多的是东南亚国家(83%)和美洲(70%) .

许多国家制定和推出的国家计划进一步吸引了大量的血小板和献血者。例如,在印度,国家艾滋病控制组织 (NACO) 内设立的国家输血委员会 (NBTC) 是与国家艾滋病控制协会内设立的国家输血委员会 (SBTC) 进行协调的中央机构(SACS)。 NBTC 支持与输血服务 (BTS) 相关的各种活动的健康计划。因此,世界各地合格捐献者数量的不断增加,促进了对用于分离所需血液成分的白细胞分离设备的需求。

产品类型-基于洞察

根据产品类型,白细胞去除术市场分为白细胞去除术设备和白细胞去除术一次性用品。 2021年,白细胞去除术一次性用品领域占据了更大的市场份额。然而,白细胞分离设备领域预计在 2021 年至 2028 年期间将实现更高的复合年增长率。

白细胞分离市场,按产品类型划分– 2021 年和 2028 年

基于应用的见解

白细胞分离术市场按应用分为研究应用和治疗应用应用程序。 2021 年,研究应用领域占据了更大的市场份额,预计该领域在未来几年将实现更高的复合年增长率。

最终用户-基于洞察

按最终用户划分,白细胞分离术市场分为制药和生物技术公司、学术和研究机构、血液成分提供商和血液中心、医院和输血中心。 2021年,血液成分供应商和血液中心细分市场占据最大份额。另一方面,预计未来几年医院和输血中心领域的复合年增长率最高。

战略见解

公司在白细胞分离术市场运营的公司正在采取产品发布、并购、合作、产品创新和产品组合扩展等策略,以扩大其在全球的足迹,维护品牌知名度,并满足最终用户不断增长的需求。

< p> 

白细胞去除术市场 –按产品类型

  • 白细胞分离装置
    • 单采装置
    • 白细胞分离柱和细胞分离器
    • 白细胞去除过滤器
    • 白细胞去除术一次性用品

    白细胞去除术市场 -按应用划分

    • 研究应用
    • 治疗应用

    白细胞去除术市场按最终用户划分

    • 制药和生物技术公司
    • 学术和研究机构
    • 血液成分提供商和血液中心
    • 医院和输血中心

    白细胞分离术市场 –按地理位置

    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • < li>欧洲
      • 法国
      • 德国
      • 意大利
      • 英国
      • 西班牙
      • 休息欧洲
    • 亚太地区 (APAC)
      • 中国
      • 印度
      • 韩国
      • 日本
      • 澳大利亚
      • 亚太地区其他地区
    • 中东和非洲非洲 (MEA)
      • 南非
      • 沙特阿拉伯
      • 阿联酋
      • 中东其他地区和地区非洲
    • 南美洲(SAM)
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区< /li>

    公司简介

    • 旭化成株式会社
    • 费森尤斯东南大学Co. KGaA
    • Haemonetics Corporation
    • Terumo Corporation
    • STEMCELL Technologies Inc.
    • HemaCare
    • Macopharma
    • Macopharma
    • STEMCELL Technologies Inc.
    • HemaCare
    • Macopharma li>
    • 所有细胞
    • STEMEXPRESS
    • BioIVT
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are leukapheresis?

Leukapheresis is a procedure that has white blood cells (leukocytes) involved in the body's immune response are segregated from a blood sample. It is a particular form of apheresis in which an element of blood, such as red blood cells or platelets, is obtained while the remaining blood is restored to circulation. Leukapheresis is often used to reduce very high white blood cell (WBC) counts, such as chronic blood cancers like chronic lymphocytic leukemia (CLL). It can also be completed to obtain white blood cells for later transplant, such as to manage abrupt declines in WBC counts throughout cancer chemotherapy. Another use is as a section of a novel form of immunotherapy, termed chimeric antigen receptor (CAR) T-cell therapy, to help fight leukemia, prostate cancer, and other forms of cancers. Leukapheresis can be completed on the person claiming treatment (autologous apheresis) or on a donor for a later transplant (allogeneic apheresis). Currently, leukapheresis is commonly used to treat various diseases, and it is also used for diagnostic purposes as it can increase circulating tumor cells yields.

What are the driving factors for the leukapheresis market across the globe?

Key factors that are driving the growth of this market are number of voluntary blood donors, increasing incidence of hematologic diseases, surge in elderly population and growing demand for leukopaks in clinical research activities boost the market growth over the years.

Which product type led the leukapheresis market?

The leukapheresis disposables segment dominated the global leukapheresis market and held the largest revenue share of 61.43% in 2021.

Which end-user held the largest share in the leukapheresis market?

The blood component providers and blood centers segment dominated the global leukapheresis market and accounted for the largest revenue share of 35.03% in 2021.

Who are the key players in the leukapheresis market?

The leukapheresis market majorly consists of the players such Asahi Kasei Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation Terumo Corporation, STEMCELL Technologies Inc., HemaCare, Macopharma, AllCells, STEMEXPRESS, and BioIVT amongst others.

What is the regional market scenario of leukapheresis?

Global leukapheresis market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for leukapheresis. The growth of the region is attributed to increasing product launches coupled with increasing patient population.
The Asia Pacific region is expected to account for the fastest growth in the leukapheresis market. Increase in government investments and a number of private biotechnology companies in this region contribute to this dominant share. The rising geriatric population and increasing investment in research are said to be responsible for this growth.

The List of Companies - Leukapheresis Market

  1. Asahi Kasei Corporation
  2. Fresenius SE & Co. KGaA
  3. Haemonetics Corporation
  4. Terumo Corporation
  5. STEMCELL Technologies Inc.
  6. HemaCare
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS
  10. BioIVT

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports